Clinical Trials Directory

Trials / Unknown

UnknownNCT02782273

Morphine Versus Ketorolac in Renal Colic

The Analgesic Effects of Morphine Versus Ketorolac in Renal Colic

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Loredana Ghinea · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is prospective, double blinded, randomised controlled and has the purpose to compare the analgesic effects of ketorolac or morphine intravenous in renal colic.

Detailed description

The study will take place in the Emergency Department of the Clinical Emergency Hospital Bucharest and will compare the analgesic effects of ketorolac tromethamine against morphine in renal colic. The patients will be randomised to receive either ketorolac 30 mg intravenous (diluted in 20 ml of 0,9% saline) or morphine 0,1 mg/kg weight intravenous. A scale of 1-10 will be used for measuring the pain, and the effects of the treatment will be evaluated at 15 minutes and 30 minutes from the administration of the drugs. After 30 minutes if there is no significant reduction of the pain a rescue therapy will be used : chlorhydrate drotaverine 40 mg, xilocaine 100 mg, both diluted in 100 ml saline and the other medication not used from the study (morphine or ketorolac tromethamine).

Conditions

Interventions

TypeNameDescription
DRUGKetorolacThe patients randomised to this arm they will receive 30 mg intravenous ketorolac.
DRUGMorphineThe patients randomised to this arm they will receive 0,1 mg/kg intravenous morphine.

Timeline

Start date
2016-05-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-05-25
Last updated
2016-05-25

Source: ClinicalTrials.gov record NCT02782273. Inclusion in this directory is not an endorsement.